7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
US-11472803-B2 · Oct 18, 2022 · US
This page is not indexed by search engines while we improve data quality.
Teller Henrik patents
Teller Henrik is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Teller Henrik |
| Total patents | 35 |
| First publication | Feb 25, 2016 |
| Latest publication | Oct 18, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
Substituted oxopyridine derivatives
US-2022144848-A1 · May 12, 2022 · US
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
US-2022089591-A1 · Mar 24, 2022 · US
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
US-2021261541-A1 · Aug 26, 2021 · US
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
US-10927109-B2 · Feb 23, 2021 · US
7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof
US-10519154-B2 · Dec 31, 2019 · US
Positive allosteric modulators of muscarinic m2 receptor
US-2019367516-A1 · Dec 5, 2019 · US
Positive allosteric modulators of muscarinic M2 receptor
US-10435403-B2 · Oct 8, 2019 · US
Substituted oxopyridine derivatives
US-10414731-B2 · Sep 17, 2019 · US
7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
US-2019263805-A1 · Aug 29, 2019 · US
Recent patents
Latest publications not already listed above.
7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof
US-2019241562-A1 · Aug 8, 2019 · US
Oxo-pyridine-derivatives as factor xia inhibitors for the treatment of thrombosis
US-2019119213-A1 · Apr 25, 2019 · US
Substituted oxopyridine derivatives and use thereof cardiovascular disorders
US-10183932-B2 · Jan 22, 2019 · US
Substituted oxopyridine derivatives
US-10167280-B2 · Jan 1, 2019 · US
Substituted oxopyridine derivatives
US-2018346424-A1 · Dec 6, 2018 · US
Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives
US-10138236-B2 · Nov 27, 2018 · US
Positive allosteric modulators of muscarinic m2 receptor
US-2018297994-A1 · Oct 18, 2018 · US
Substituted oxopyridine derivatives
US-10077265-B2 · Sep 18, 2018 · US
Substituted oxopyridine derivatives
US-10071995-B2 · Sep 11, 2018 · US
Substituted oxopyridine derivatives
US-2018127401-A1 · May 10, 2018 · US
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
US-2018086742-A1 · Mar 29, 2018 · US
Substituted oxopyridine derivatives and use thereof as factor XIa/plasma
US-9918969-B2 · Mar 20, 2018 · US
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
US-9822102-B2 · Nov 21, 2017 · US
Substituted oxopyridine derivatives
US-2017298052-A1 · Oct 19, 2017 · US
Substituted oxopyridine derivatives
US-2017291892-A1 · Oct 12, 2017 · US
Substituted oxopyridine derivatives
US-2017283412-A1 · Oct 5, 2017 · US
Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives
US-2017275282-A1 · Sep 28, 2017 · US
Substituted oxopyridine derivatives
US-9765070-B2 · Sep 19, 2017 · US
Substituted oxopyridine derivatives and use thereof as factor xia/plasma
US-2017035739-A1 · Feb 9, 2017 · US
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
US-2016368903-A1 · Dec 22, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Pharma AG | 35 |
| Bayer Ag | 8 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P7/02 | 21 |
| A61P27/02 | 20 |
| C07D471/04 | 20 |
| A61P29/00 | 16 |
| C07D401/12 | 15 |